Dr. Wenge Zhu's research lab at George Washington University focuses on understanding and overcoming resistance to breast cancer therapies. The lab investigates how specific molecular pathways influence both CDK4/6 inhibitor and aromatase inhibitor resistance, aiming to develop novel therapeutic strategies for patients with advanced breast cancer. By studying the roles of specific proteins and gene mutations, Dr. Zhu's team seeks to improve treatment outcomes for affected patients.